Objective to investigate the change of the insulin degrading enzymeactivity of erythrocytes (EIDEA) in patients with chronic hepatitis b, and to reveal the ability of the liver for degrading insulin.
Serum enzymeactivity of the liver in DFL has not changed.
DFL患者的肝酶活性一般没有明显变化。
3
The circadian expression of clock genes and components of adiponectin metabolic pathway in the liver was tested at the RNA, protein, or enzymeactivity level.